ÀÏÀß·¯Ã¤¿ë°ü
ä¿ëÁ¤º¸
ÀÎÀç°Ë»ö
±³À°Á¤º¸
ÇìµåÇåÆÃ
½º¸¶Æ®Å¸¿î
ȸ¿ø¼­ºñ½º
À̷¼­ µî·Ï
ä¿ë°ø°í µî·Ï

ÀÓ»ó½ÃÇèºÎ - Site Activation Partner II

Çѱ¹È­ÀÌÀÚÁ¦¾à(ÁÖ)

http://www.pfizer.co...

°ü½É±â¾÷

¾÷Á¾ ÀÇ·á/Á¦¾à/°Ç°­ ÀÚº»±Ý
±â¾÷ÇüÅ ¿Ü±¹±â¾÷ ¸ÅÃâÇöȲ
´ëÇ¥ÀÚ »ç¿ø¼ö
ȸ»çÁÖ¼Ò ¼­¿ï Áß±¸ ȸÇöµ¿3°¡ È­ÀÌÀÚŸ¿ö
  • ÇöÀç ä¿ëÁ¤º¸¸¦ º¹»çÇÕ´Ï´Ù.
  • ÇöÀç ä¿ëÁ¤º¸¸¦ ÇÁ¸°ÆÃÇÕ´Ï´Ù.




Á÷Á¾ »ç¹«¡¤Ãѹ«¡¤¹ý¹«, Á¦¾à¡¤ÀǾà
±Ù¹«ÇüÅ Á¤±ÔÁ÷ ä¿ëÁ÷±Þ -
¸ðÁýÀοø 0 ¸í ³ªÀÌ -
°æ·Â °æ·Â ±Þ¿©Á¶°Ç ´ç»ç±ÔÁ¤
Çз ´ëÁ¹ ÀÌ»ó Á¢¼ö±â°£ Á¢¼ö±â°£ÀÌ Áö³µ½À´Ï´Ù
 [ȨÆäÀÌÁöÁ¢¼ö]

Á¢¼ö±â°£ÀÌ Áö³µ½À´Ï´Ù

* ´ã´ç¾÷¹«
»ó¼¼Á¶°Ç

ÀÓ»ó½ÃÇèºÎ - Site Activation Partner II

¸ðÁýºÎ¹® ¹× ÀÚ°Ý¿ä°Ç

¸ðÁýºÎ¹®  »ó¼¼³»¿ë 

ÀÓ»ó½ÃÇèºÎ
Site Activation Partner II
 

ROLE SUMMARY:

 

The Site Activation Partner is responsible for leading and supporting operational activities, from start-up to close-out, for assigned studies and investigator sites to ensure compliance with study timelines and in accordance with prevailing laws, Good Clinical Practices, and Pfizer standards.

 

Responsibility span within a country or multi-country depending on the geographical region and business needs

 

 

ROLE RESPONSIBILITIES:

 

Clinical Trial Site Activation

 

Take the Lead, initiate and coordinates activities related to compilation of high-quality IRB/EC package and ensure timely submission to approval and other committees as per country requirements

 

Support investigators sites with local IRB workflow from preparation, submission through approval

 

Collaborate with in country regulatory group, and other stakeholders and provide related/applicable site documents as applicable

 

Coordinate the timely communication, documentation and responses between Pfizer and Ethics committees/sites to bring clinical study to approval

 

Initiate and coordinate activities and essential documents management towards the compilation of a high-quality Investigator Initiation Package (IIP) leading to approval for sites initiation

 

Prepare, validate and submit essential documents for internal sponsor regulatory group approval within required timelines

 

Manage and coordinate with other supporting roles to ensure timely site activation and operational activities.

 

Collaborate with the Study Team on the development and readiness of sites eISF when utilized

 

Support & implement activities in Shared Investigator Platform to align with Pfizer strategy

 

Coordinate translation of documents that are within scope with the preferred translation vendors

 

Accurately update and maintain clinical trial systems that track site compliance and performance within project timelines

 

Responsible for timely filing of documents to Trial Master File and assisting with periodic quality review of study files for accuracy and completeness

 

 

​Clinical Trials Conduct

 

Ensure continuation of IRB/Ethic¡¯s and other committees activities Post SIV, and related submission, notifications, reapprovals etc..

 

Post site activation, maintain the coordination of activities of essential documents updates and management with the investigator¡¯s sites through the life cycle of a study

 

Maintain TMF and systems during study conduct

 

Supports investigator sites, and study teams in preparation for and providing responses to site audits / inspections

 

 

​Additional Responsibilities:

 

Be a Subject Matter Expert on one or more system and/or process

 

Represent the SAP role on global initiatives

 

 

 

QUALIFICATIONS:

 

School diploma/certificate with equivalent combination of education, training and experience BS/BA or bachelor¡¯s degree in life sciences preferred

 

Minimum 4 years relevant experience in Clinical Trials environment, Ethics environment and clinical site activation.

 

Experience working in the pharmaceutical industry or CRO in a similar role

 

Demonstrated deep knowledge of clinical trial methodologies, ICH/GCP, Global and local country regulations

 

Deep understanding of the Site Activation requirements and processes within the country

 

Must be fluent in Local language and in English. Multilingual capability is an asset

 

Effective verbal and written communication skills relating to colleagues and associates both inside and outside of the organization

 

Good technical skills and ability to learn and use multiple systems e.g CTMS, Network portals, SIP etc..

 

Experience working in a global environment

 

Experience in working in more than 1 country is an asset

 

 

 

PHYSICAL/MENTAL REQUIREMENTS:

 

Ability to work under pressure to meet deadlines

 

Understand the quality expectations and emphasis on right first time.

 

Attention to detail evident in a disciplined approach

 

Proven ability to work independently and also as a team member

 

Ability to organize tasks, time and priorities, ability to multi-task

 

Able to manage a high volume of, complex studies and sites

 

Flexible and adapt to off working hours in a global environment (when applicable) 

±Ù¹«Á¶°Ç

  • - ±Ù¹«ÇüÅ : Á¤±ÔÁ÷
  • - ±Ù¹«Áö¿ª : ¼­¿ï Áß±¸

ÀüÇüÀýÂ÷

  • - ¼­·ùÀüÇü > ¸éÁ¢ÀüÇü > ÃÖÁ¾ÇÕ°Ý

Á¦Ãâ¼­·ù

  • - ±¹¹®/¿µ¹®À̷¼­, ÀÚ±â¼Ò°³¼­ ¹× °³ÀÎÁ¤º¸Ã³¸® µ¿ÀǼ­(°¢Á¾ Áõºù¼­·ù´Â ¼­·ùÀüÇüÇÕ°ÝÀÚ¿¡ ÇÑÇØ ÃßÈÄ Á¦Ãâ)
  • - Pfizer ä¿ë »çÀÌÆ®¸¦ ÅëÇÑ Áö¿ø ÀÌ¿ÜÀÇ À̸ÞÀÏ ¹× ¿ìÆíÁ¢¼ö µîÀº ¹ÞÁö ¾ÊÀ¸¸ç, ¼­·ùÀüÇü ÇÕ°ÝÀÚ¿¡ ÇÑÇؼ­¸¸ °³º° ÅëÁöµÇ´Â Á¡ ¾çÇØ ºÎŹµå¸³´Ï´Ù.
  • ¡Ø º¸ÈÆ ´ë»óÀÚ´Â Áö¿ø ½Ã °ü·Ã¼­·ù¸¦ ÇÔ²² Á¦Ãâ

Á¢¼ö±â°£ ¹× ¹æ¹ý

  • - Á¢¼ö±â°£ : 2021.04.22 ~ 2021.05.07±îÁö
  • - Á¢¼ö¹æ¹ý : ȨÆäÀÌÁöÁö¿ø(https://pfizer.wd1.myworkdayjobs.com/PfizerCareers/job/Korea-Republic-of-Seoul/XMLNAME-Site-Activation-Partner-II_4811511-1)
  • ¡Ø ¸µÅ© Ŭ¸¯ ÈÄ ¿ìÃø »ó´ÜÀÇ ·Î±×ÀΠŬ¸¯ ÈÄ °èÁ¤»ý¼º > ¹ß¼ÛµÈ À̸ÞÀÏ È®ÀÎÇÏ¿© °èÁ¤ È°¼ºÈ­ ÈÄ ·Î±×ÀÎ > Á÷¹«°Ë»ö > 4811511°Ë»ö > Áö¿ø
  • ¡Ø Áö¿ø¼­·ù ¹× °³ÀÎÁ¤º¸µ¿ÀǼ­ ¾÷·Îµå ÈÄ ÀýÂ÷¿¡ µû¶ó Áö¿ø ¿Ï·á

±âŸ

  • - º´¿ªÇÊ ¶Ç´Â ¸éÁ¦ÀÚ
  • - ÇØ¿Ü¿©Çà¿¡ °á°Ý»çÀ¯°¡ ¾ø´Â ÀÚ
  • - ÇãÀ§»ç½ÇÀÌ ¹ß°ßµÉ °æ¿ì ä¿ëÀÌ Ãë¼ÒµÉ ¼ö ÀÖ½À´Ï´Ù.
  • - ´ç»ç´Â ä¿ë ÀýÂ÷ÀÇ °øÁ¤È­¿¡ °üÇÑ ¹ý·ü(ÀÌÇÏ Ã¤¿ëÀýÂ÷¹ý)¿¡ ÀÇ°ÅÇÏ¿©, ä¿ë °úÁ¤ Áß ¾÷¹«¿Í ¹«°üÇÑ ÀÏüÀÇ °³ÀÎÁ¤º¸¸¦ ¹¯°Å³ª ¿ä±¸ÇÏÁö ¾Ê½À´Ï´Ù. À̷¼­ ¹× ÀÚ±â¼Ò°³¼­¿¡ Áֹεî·Ï¹øÈ£, °áÈ¥À¯¹«, °¡Á·»çÇ× ¹× ±âŸ ä¿ëÀýÂ÷¹ý¿¡¼­ ¼öÁýÀ» ±ÝÁöÇÏ´Â °³ÀÎ Á¤º¸ÀÇ ±âÀ縦 ±ÝÁöÇÏ°í ÀÖ½À´Ï´Ù.




* ÀÔ»çÁö¿ø ½Ã Áß¿ä»çÇ×À» ²À üũÇϼ¼¿ä!

* ±Ù¹«È¯°æ
±Ù¹«Áö¿ª : ¼­¿ï
±Þ¿©Á¶°Ç : ´ç»ç±ÔÁ¤
* Á¢¼ö°³¿ä

¿À´Ã¸¶°¨

Á¢¼ö±â°£ÀÌ Áö³µ½À´Ï´Ù

¡á Á¢¼ö±â°£   ¡á ¿À´Ã   ¡á ¸¶°¨

2021. 04

  • ÀÏ
  • ¿ù
  • È­
  • ¼ö
  • ¸ñ
  • ±Ý
  • Åä
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30

2021. 05

  • ÀÏ
  • ¿ù
  • È­
  • ¼ö
  • ¸ñ
  • ±Ý
  • Åä
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
* ´ã´çÀÚ Á¤º¸
¸ðÁý±â°£ÀÌ Áö³­ ä¿ëÁ¤º¸ÀÇ °æ¿ì ´ã´çÁ¤º¸´Â °ø°³µÇÁö ¾Ê½À´Ï´Ù.
ÇöÀç ä¿ëÁ¤º¸¸¦ º¹»çÇÕ´Ï´Ù. ÇöÀç ä¿ëÁ¤º¸¸¦ ÇÁ¸°ÆÃÇÕ´Ï´Ù.

µî·Ï : 2021³â 4¿ù 22ÀÏ (¸ñ) 23:11    ÃÖÁ¾¼öÁ¤ : 2021³â 4¿ù 22ÀÏ (¸ñ) 23:11

º» Á¤º¸´Â Çѱ¹È­ÀÌÀÚÁ¦¾à(ÁÖ) ¿¡¼­ Á¦°øÇÑ ÀÚ·áÀ̸ç, ½ºÄ«¿ìÆ®Àº(´Â) ±× ³»¿ë»óÀÇ ¿À·ù ¹× Áö¿¬, ±× ³»¿ëÀ» ½Å·ÚÇÏ¿© ÃëÇØÁø Á¶Ä¡¿¡ ´ëÇÏ¿© Ã¥ÀÓÀ» ÁöÁö ¾Ê½À´Ï´Ù. º» Á¤º¸´Â ½ºÄ«¿ìÆ®ÀÇ µ¿ÀÇ ¾øÀÌ Àç¹èÆ÷ÇÒ ¼ö ¾ø½À´Ï´Ù.

¢À ½ºÄ«¿ìÆ® ¿¡¼­´Â °ÅÁþ ±¸ÀÎ ±¤°í¿¡ ´ëÇÑ ÇÇÇظ¦ ÃÖ¼ÒÈ­ Çϱâ À§ÇÏ¿© ÇãÀ§ ä¿ë°ø°í¿¡ ½Å°íÁ¦µµ¸¦ ½ÃÇàÇÏ°í ÀÖ½À´Ï´Ù.
°ÅÁþ±¸Àα¤°í¿¡ ´ëÇÑ ±¸Á÷ÀÚÁÖÀÇ»çÇ× ½Å°íÆ÷»ó±ÝÁ¦ ¾È³» ÇãÀ§ ä¿ë°ø°í ½Å°íÇϱâ

±Ù¹«Áö À§Ä¡ º¸±â

±Ù¹«Áö ÁÖ¼Ò

(100-053) ¼­¿ï Áß±¸ ȸÇöµ¿3°¡ È­ÀÌÀÚŸ¿ö

Å©°Ôº¸±â

[ƯÁý±âȹ] ¹ý·ü»ç¹«Á÷

Á÷¾÷µ¸º¸±â

¹ý·ü»ç¹«Á÷À̶õ?º¯..

¸éÁ¢ helper

¸éÁ¢Áú¹®

Àμº ¡Ú¡Ú¡Ú¡Ú
Àû¼º ¡Ú¡Ú¡Ú¡Ú

Special Interview

½ºÆä¼ÈÀÎÅͺä
¹ý·ü »ç¹«Á÷À̶ó´Â ÀÏÀÌ ¾î¶² ÀÏÀÎÁö Àß ¸ð..